Teva Pharmaceutical Industries will pay a $22 million fine to the state of Israel to settle charges related to anti-bribery violations. Last year the company agreed to pay $519 million fine to the US.
Teva is the world largest producer of generic drug.
The company was accused of making illegal payments to government officials in Russia, Ukraine, and Mexico. After the judicial decision made by US in 2016, an investigation was opened by Israel, and as in the American case, Teva admitted making illegal payments to government officials.
Thanks to these illegal payments, between 2007-2012 the company netted a profit of over $221 million.
The state attorney signed up the agreement requested Teva to pay the whole amount within two months. In his report, the public prosecutor took into account the Teva’s current financial troubles and its status as a major employer in Israel among other reasons, to make a decision.
Indeed the company debt was estimated at $32 billion. A result due to its 2016 Actavis acquisition, and to a lack of revenues in consequence of the declining generic drug market.
Teva launched last December an extensive reorganization plan that will lay off 14.000 employees around the world. In Israel 1 700 of them are concerned.
Discover out our latest videos about the economic news in Israel :